Finnish health food group Raisio has revealed a new business structure to align with its recently announced three-year strategy plan.
In a statement, Raisio said the reorganisation will impact its organisation, operating model and leadership team, with new appointments made.
The publicly listed company will rearrange its business model into two category-focused areas: breakfast, snacking and food solutions combined, and heart health.
A third unit will focus on new business development and will be overseen by CEO Pasi Flinkman.
Flinkman said: “With the new organisation, we aim for holistic, accountable management and fast, consumer-oriented decision-making. The new structure enables effective implementation of the strategy and enhances cost-efficiency.”
The organisational reform will also alter the group’s financial reporting structure split between brands and industrial, and other operations.
The brands and industrial segment will encompass the breakfast, snacking and food solutions, and heart health units, focusing on consumer and B2B business, with Europe as the main market area. The key Benecol and Elovena brands will sit within that reporting division.
The other operations segment will cover new business development and shared functions.
In March, the owner of the Benecol cholesterol-fighting yogurt and spreads brand set a goal to achieve €250m ($271.3m) in revenue by the end of 2027, representing a more than 10% increase in organic terms from last year’s print of €227m.
Raisio is also targeting EBIT of €30m during the strategy period, reflecting a roughly 28% increase from the €23m reported in 2024.
As part of the leadership reorganisation, Noora Pöyhönen has been appointed as chief business officer for the breakfast, snacking and food solutions unit.
She will join Raisio from her current role as vice president of biscuits and crisps at Finnish food peer Fazer, with an expected start in the first quarter of 2026.
Mikko Lindqvist, formerly Raisio’s chief sales officer, has been appointed as chief business officer for heart health.
Raisio said the role of chief development officer for the group business will be “terminated”, meaning Olavi Erkinjuntti will leave the company.
As a result of the changes, 14 positions will be eliminated, with nine through employment terminations and the rest via retirement. Initially, 20 jobs were expected to be cut but new positions have been created through the restructure.
Raisio plans to release its first half-year financial report for 2025, reflecting the new structure, on 12 August.
